Deutsche Bank Ag\ Macrogenics Inc Transaction History

Deutsche Bank Ag\

$240 Billion
Q3 2024

A detailed history of Deutsche Bank Ag\ transactions in Macrogenics Inc stock. As of the latest transaction made, Deutsche Bank Ag\ holds 43,855 shares of MGNX stock, worth $142,967. This represents 0.0% of its overall portfolio holdings.

Number of Shares

43,855

Previous 33,564 30.66%

Holding current value

$142,967

Previous $142,000 1.41%

% of portfolio

0.0%

Previous 0.0%

32 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$3.0 - $5.55 $30,873 - $57,115	10,291 Added 30.66%	43,855 $144,000
Q2 2024 Aug 14, 2024	SELL	$3.31 - $18.51 $19,317 - $108,024	-5,836 Reduced 14.81%	33,564 $142,000
Q1 2024 May 15, 2024	SELL	$9.77 - $21.47 $1.46 Million - $3.2 Million	-148,932 Reduced 79.08%	39,400 $579,000
Q4 2023 Feb 14, 2024	BUY	$4.48 - $10.11 $731,032 - $1.65 Million	163,177 Added 648.69%	188,332 $1.81 Million
Q3 2023 Nov 09, 2023	SELL	$4.48 - $6.19 $703,713 - $972,319	-157,079 Reduced 86.2%	25,155 $117,000
Q2 2023 Aug 14, 2023	SELL	$4.62 - $7.54 $76,899 - $125,503	-16,645 Reduced 8.37%	182,234 $974,000
Q1 2023 May 15, 2023	BUY	$4.82 - $7.24 $56,953 - $85,547	11,816 Added 6.32%	198,879 $1.43 Million
Q4 2022 Feb 13, 2023	BUY	$3.34 - $6.98 $542,095 - $1.13 Million	162,304 Added 655.54%	187,063 $1.26 Million
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $718,914 - $1.25 Million	-238,842 Reduced 90.61%	24,759 $86,000
Q2 2022 Aug 11, 2022	BUY	$2.25 - $9.99 $508,853 - $2.26 Million	226,157 Added 603.99%	263,601 $778,000
Q1 2022 May 13, 2022	SELL	$8.12 - $16.9 $30,872 - $64,253	-3,802 Reduced 9.22%	37,444 $330,000
Q4 2021 Feb 11, 2022	BUY	$15.91 - $21.88 $28,749 - $39,537	1,807 Added 4.58%	41,246 $662,000
Q3 2021 Nov 04, 2021	SELL	$19.74 - $28.7 $9,593 - $13,948	-486 Reduced 1.22%	39,439 $826,000
Q2 2021 Aug 11, 2021	BUY	$20.49 - $35.63 $54,667 - $95,060	2,668 Added 7.16%	39,925 $1.07 Million
Q1 2021 May 13, 2021	SELL	$18.99 - $33.2 $38,093 - $66,599	-2,006 Reduced 5.11%	37,257 $1.19 Million
Q4 2020 Feb 16, 2021	BUY	$19.41 - $26.0 $183,016 - $245,154	9,429 Added 31.6%	39,263 $897,000
Q3 2020 Nov 12, 2020	SELL	$24.69 - $31.6 $1.13 Million - $1.44 Million	-45,599 Reduced 60.45%	29,834 $752,000
Q2 2020 Aug 13, 2020	SELL	$5.2 - $29.12 $631,441 - $3.54 Million	-121,431 Reduced 61.68%	75,433 $2.11 Million
Q1 2020 May 14, 2020	SELL	$4.28 - $12.11 $142,468 - $403,105	-33,287 Reduced 14.46%	196,864 $1.15 Million
Q4 2019 Feb 14, 2020	BUY	$7.95 - $12.27 $635,777 - $981,256	79,972 Added 53.25%	230,151 $2.5 Million
Q3 2019 Nov 14, 2019	BUY	$12.44 - $17.48 $704,626 - $990,102	56,642 Added 60.56%	150,179 $1.92 Million
Q2 2019 Aug 14, 2019	SELL	$14.51 - $19.71 $2.35 Million - $3.19 Million	-161,955 Reduced 63.39%	93,537 $1.59 Million
Q1 2019 May 15, 2019	BUY	$11.11 - $25.6 $2.67 Million - $6.16 Million	240,746 Added 1632.62%	255,492 $4.59 Million
Q4 2018 Feb 14, 2019	SELL	$11.75 - $21.42 $1.34 Million - $2.44 Million	-113,989 Reduced 88.55%	14,746 $185,000
Q3 2018 Dec 21, 2021	BUY	$19.26 - $23.46 $875,270 - $1.07 Million	45,445 Added 54.56%	128,735 $2.76 Million
Q3 2018 Nov 14, 2018	SELL	$19.26 - $23.46 $616,474 - $750,907	-32,008 Reduced 27.76%	83,290 $1.78 Million
Q2 2018 Apr 21, 2020	BUY	$19.78 - $24.67 $392,237 - $489,206	19,830 Added 20.77%	115,298 $2.38 Million
Q2 2018 Aug 14, 2018	SELL	$19.78 - $24.67 $2.54 Million - $3.17 Million	-128,456 Reduced 57.37%	95,468 $1.97 Million
Q1 2018 Oct 18, 2019	BUY	$18.89 - $32.46 $664,342 - $1.14 Million	35,169 Added 18.63%	223,924 $5.63 Million
Q1 2018 May 15, 2018	SELL	$18.89 - $32.46 $625,202 - $1.07 Million	-33,097 Reduced 14.92%	188,755 $4.75 Million
Q4 2017 Feb 14, 2018	BUY	$16.19 - $20.3 $1.63 Million - $2.05 Million	100,834 Added 83.32%	221,852 $4.21 Million
Q3 2017 Nov 14, 2017	BUY	$15.52 - $18.94 $1.88 Million - $2.29 Million	121,018	121,018 $2.24 Million

Others Institutions Holding MGNX

# of Institutions

132

Shares Held

55.4M

Call Options Held

215K

Put Options Held

238K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $200M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Deutsche Bank Ag\, based on Form 13F filings with the SEC.

News

Stay updated on Deutsche Bank Ag\ with notifications on news.

Account